To view PDF documents
External links included in this website should not be construed as an official endorsement of the views contained therein.
|
What's New
June 2013
- Pharmacy Diversion Awarness Conferences
- Manufacturer/Importer/Exporter Conference
- Clarification of Title 21 CFR 1301.90 - Employee Screening - Non-Practitioners
- 30-Day Notice - Comments Requested: Import/Export Declaration for List I and List II
Chemicals; DEA Forms 486 and 486A (June 18, 2013)
- 30-Day Notice - Comments Requested: Extension With Change of a Previously Approved
Collection: National Drug Threat Survey (June 18, 2013)
- Belinda R. Mori, N.P.; Decision and Order (June 18, 2013)
- Lipomed (June 18, 2013)
- GE
Healthcare (June 18, 2013)
- National Center for Natural Products Research-NIDA; Correction (June 18, 2013)
- David M. Lewis, D.M.D., Dismissal of Proceeding (June 18, 2013)
- Noramco, Inc. (June 11, 2013)
- Watson
Pharma, Inc. (June 4, 2013)
- Rhodes
Technologies (June 4, 2013)
- Mylan
Technologies, Inc. (June 4, 2013)
- Caraco
Pharmaceutical Laboratories, LTD (June 4, 2013)
- Agilent Technologies (June 4, 2013)
- Penick Corporation (June 4, 2013)
- Sigma Aldrich Research Biochemicals, Inc. (June 4, 2013)
- Cerilliant Corporation (June 4, 2013)
- GE
Healthcare (June 4, 2013)
- Pharmagra Labs, Inc. (June 4, 2013)
- Alltech Associates, Inc. (June 4, 2013)
- Norac, Inc. (June 4, 2013)
May 2013
- United
States Pharmacopeial Convention (May 30, 2013)
- United
States Pharmacopeial Convention (May 30, 2013)
- Siegfried USA, LLC. (May 30, 2013)
- Sigma Aldrich Research Biochemicals, Inc. (May 30, 2013)
- Mallinckrodt, LLC. (May 30, 2013)
- Wildlife Laboratories Inc. (May 22, 2013)
- Alltech Associates, Inc. (May 22, 2013)
- Arizona Department of Corrections (May 22, 2013)
- Meridian Medical Technologies (May 22, 2013)
- Alltech Associates, Inc. (May 22, 2013)
- Austin Pharma, LLC. (May 22, 2013)
- Lin
Zhi International, Inc. (May 22, 2013)
- Siegfried (USA), LLC. (May 22, 2013)
- Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cannabinoids Into Schedule I (May 16, 2013)
- Leo A. Farmer, M.D.; Decision and Order (May 13, 2013)
- Jose G. Zavaleta, M.D.; Decision and Order (May 10, 2013)
- Schedules of Controlled Substances: Placement of Lorcaserin Into Schedule IV (May 8, 2013)
- Top RX Pharmacy; Decision and Order (May 3, 2013)
April 2013
- Lipomed (April 23, 2013)
- Fisher
Clinical Services, Inc. (April 23, 2013)
- Research Triangle Institute (April 23, 2013)
- Wildlife Laboratories, Inc. (April 23, 2013)
- S & B Pharma Inc. (April 23, 2013)
- Alltech Associates, Inc. (April 23, 2013)
- PCAS-Nanosyn, LLC (April 23, 2013)
- Cayman Chemical Company (April 23, 2013)
- Rhodes
Technologies (April 19, 2013)
- Catalent CTS., Inc. (April 19, 2013)
- Almac
Clinical Services, Inc., (ACSI) (April 19, 2013)
- GE
Healthcare (April 19, 2013)
- Nebraska State Penitentiary (April 19, 2013)
- Penick Corporaton (April 19, 2013)
- Rhodes Technologies (April 19, 2013)
- American Radiolabeled Chemicals, Inc. (April 19, 2013)
- Navinta, LLC. (April 19, 2013)
- National Center for Natural Products Research-NIDA MProject (April 19, 2013)
- Schedules of Controlled Substances: Temporary Placement of Three
Synthetic Cannabinoids Into Schedule I (April 12, 2013)
- Schedules of Controlled Substances: Placement of Methylone Into
Schedule I (April 12, 2013)
- 60-Day Notice - Comments Requested: National Drug Threat Survey; Extension With Change
of a Previously Approved Collection (April 3, 2013)
March 2013
- 60-Day Notice - Comments Requested: Import/Export Declaration for List I and List II
Chemicals, DEA Forms 486 and 486A (March 29, 2013)
- Gary Alfred Shearer, M.D.; Decision And Order (March 28, 2013)
- Pawan Kumar Jain, M.D.; Decision And Order (March 28, 2013)
- Stepan
Company (March 28, 2013)
- SA INTL
GMBH C/O., Sigma Aldrich Co. LLC (March 28, 2013)
- Johnson Matthey, Inc. (March 28, 2013)
- Mylan
Pharmaceuticals, Inc. (March 28, 2013)
- Patheon Pharmaceuticals, Inc. (March 28, 2013)
- Johnson Matthey Pharmaceutical Materials, Inc. (March 28, 2013)
- Siemens Healthcare Diagnostics, Inc. (March 28, 2013)
- Electronic Prescriptions for Controlled Substances Notice of
Approved Certification Process (March 26, 2013)
- Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV (March 25, 2013)
- Noramco
Inc. (March 20, 2013)
- United
States Pharmacopeial Convention (March 20, 2013)
- Noramco, Inc. (March 20, 2013)
- Watson
Pharma, Inc. (March 20, 2013)
- Morton Grove Pharmaceuticals (March 20, 2013)
- Noramco, Inc. (March 20, 2013)
- 30-Day Notice - Comments Requested: Reporting and Recordkeeping for Digital
Certificates (March 15, 2013)
- Johnson Matthey, Inc. (March 14, 2013)
- Meridian Medical Technologies (March 13, 2013)
- Hospira Inc. (March 13, 2013)
- Johnson Matthey, Inc., Pharmaceuticals Materials (March 13, 2013)
February 2013
- Brian Earl Cressman, M.D.; Decision and Order (February 21, 2013)
- John V. Scalera; Decision and Order (February 21, 2013)
- Meda
Pharmaceuticals, Inc. (February 21, 2013)
- Mallinckrodt, LLC. (February 21, 2013)
- Caraco
Pharmaceutical Laboratories, LTD. (February 21, 2013)
- Mallinckrodt, LLC (February 21, 2013)
- Pharmagra Labs, Inc. (February 21, 2013)
- Sigma Aldrich Research Biochemicals, Inc. (February 21, 2013)
- GE
Healthcare (February 21, 2013)
- Alltech Associates, Inc. (February 21, 2013)
- Cody Laboratories, Inc. (February 21, 2013)
- Cedarburg Pharmaceuticals, Inc. (February 21, 2013)
- INB Hauser Pharmaceutical Services, Inc. (February 21, 2013)
- 30-Day Notice - Comments Requested: Application for Individual Manufacturing Quota for
a Basic Class of Controlled Substance and for Ephedrine,
Pseudoephedrine, and Phenylpropanolamine (February 8, 2013)
- 30-Day Notice - Comments Requested: Application for Procurement Quota for Controlled
Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine (February 8, 2013)
- 30-Day Notice - Comments Requested: Report of Mail Order Transaction (February 8, 2013)
- GE
Healthcare (February 6, 2013)
- Sanjay Trivedi, M.D.; Decision and Order (February 4, 2013)
January 2013
- 30-Day Notice - Comments Requested: Application for Registration Under Domestic
Chemical Diversion Control Act of 1993 and Renewal Application for
Registration Under Domestic Chemical Diversion Control Act of 1993; DEA
Forms 510 and 510a (January 30, 2013)
- 30-Day Notice - Comments Requested: Annual Reporting Requirement for Manufacturers of
Listed Chemicals (January 30, 2013)
- PCAS-Nanosyn, LLC (January 30, 2013)
- Mylan
Technologies, Inc. (January 29, 2013)
- Alkermes Gainesville, LLC (January 29, 2013)
- Fisher
Clinical Services, Inc. (January 25, 2013)
- Nebraska State Penitentiary (January 25, 2013)
- R & D
Systems, Inc. (January 25, 2013)
- Myoderm (January 25, 2013)
- Chattem Chemicals, Inc. (January 25, 2013)
- Cerilliant Corporation (January 25, 2013)
- Sigma Aldrich Research Biochemicals, Inc. (January 25, 2013)
- Johnson Matthey, Inc. (January 25, 2013)
- Ampac Fine Chemicals, LLC (January 25, 2013)
- Siegfried (USA) (January 25, 2013)
- Chemic Laboratories, Inc. (January 25, 2013)
- Noramco, Inc. (January 25, 2013)
- Cerilliant Corporation (January 25, 2013)
- Morton Grove Pharmaceuticals (January 25, 2013)
- Order With Opportunity for Comment - Exempt Chemical Preparations Under the Controlled Substances Act (January 22, 2013)
- 30-Day Notice - Comments Requested: Collection of Laboratory Analysis Data on Drug
Samples Tested by Non-Federal (State and Local) Crime Laboratories (January 14, 2013)
- 60-Day Notice - Comments Requested: Reporting and Recordkeeping for Digital
Certificates (January 11, 2013)
- Establishment of Drug Codes for 26 Substances (January 4, 2013)
|
|
